Skip to main content
SpringerLink
Log in

Zusammenfassung: immunologische Reaktionsabläufe bei malignen Erkrankungen

  • Conference paper
Malignome und Hämostase

  • 21 Accesses

Zusammenfassung

Der vorliegende Beitrag behandelt neuere Erkenntnisse über Immunreaktion gegenüber Tumoren. Dieses schließt die Identifizierung neuer tumorassoziierte Antigene sowie die Regulation von Antitumorimmunreaktionen durch Zytokine, akzessorische Molekülen und Wachstumsfaktoren ein. TumorWirtsinteraktionen führen auch zur Generierung von Tumor-ImmunescapeVarianten, die ebenfalls diskutiert werden. Schließlich werden Ansätze zu Immun- und Gentherapien erläutert und es wird kurz auf einige Probleme bei der Durchführung klinischer Krebsimmuntherapiestudien eingegangen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Altevogt P, Hoegen P von, Schirrmacher V (1986) Immunoresistant metastatic tumor variants can re-express their tumor antigen after treatment with DNA methylation-inhibiting agents. Int J Cancer 38: 707–711

    Article  PubMed  CAS  Google Scholar 

  • Barnd Di, Lan MS, Metzgar RS, Finn OJ (1989) Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Sci USA 86: 7159–7163

    Article  CAS  Google Scholar 

  • Bosslet K, Schirrmacher V (1982) High-frequency generation of new immunoresistant tumor variants during metastasis of a cloned murine tumor line ( ESb ). Int J Cancer 29: 195–202

    Article  PubMed  CAS  Google Scholar 

  • Chen L, Ashe S, Bradey WA, Hellström I, Hellström KE, Ledbetter JA, McGowan P, Linsley PS (1992) Costimulation of anti-tumor immunity by the B7 counter-receptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71: 1093–1102

    Article  PubMed  CAS  Google Scholar 

  • Fearon E, Pardoll D, Itaya T et al. (1990) Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 6o: 397–403

    Article  Google Scholar 

  • Foa R, Giovarelli M, Jemma C, Pierro MT, Lusso P, Ferrando ML, Lauria F and Forni G (1985) Interleukin-2 (II-2) and interferon-y production by T lymphocytes from patients with B-chronic lymphoytic leukemia: evidence that normally released II-2 is absorbed by the neoplastic B cell population. Blood 66: 2614–2619

    Google Scholar 

  • Gansbacher B, Zier K, Daniels B, Cronin K, Bannedi R, Gilboa E (1990 a) Interleukin-2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J Exp Med 172: 1217–1224

    Google Scholar 

  • Gansbacher B, Bannerji R, Daniels B, Zier K, Cronin K, Giboa E (1990 b) Retroviral vector-mediated gamma interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Cancer Res 50: 7820–7825

    Google Scholar 

  • Kast WM, Offringa R, Peters PJ, Voordouw AC, Meloen RH, Van der Eh AJ, Melief CJ (1989) Eradication of adenovirus E1-induced tumors by EiA-specific cytotoxic T lymphocytes. Cell 59: 603–614

    Article  PubMed  CAS  Google Scholar 

  • Kiyokawa T, Shirono K, Hattori T, Nishimura H, Yamaguchi K, Nichols JC, Murphy AR, Takatsuki K (1989) Cytotoxicity of interleukin-2 toxin towards lymphocytes from patients with adult T cell leukemia. Cancer Res 49: 4042–4046

    PubMed  CAS  Google Scholar 

  • Lassam N, Jay G (1989) Suppression of MHC class I RNA in highly oncogenic cells occurs at the level of transcription initiation. J Immunol 143: 3792–3797

    PubMed  CAS  Google Scholar 

  • Lenschow DJ, Zeng Y, Thisthlewaite JR, Montag A, Brady W, Gibson ML, Linsley PS, Bluestone JA (1992) Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA41g. Science 257: 789–792

    Article  PubMed  CAS  Google Scholar 

  • Lurquin C, Van Pel AL, Marianne B et al. (1989) Structure of the gene of tum-transplantation antigen P91 A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells. Cell 58: 293–303

    Article  PubMed  CAS  Google Scholar 

  • Maki RG, Old LJ, Strivastava PK (1990) Human homologue of murine tumor rejection antigen gp 96: 5’ regulatory and coding regions and relationship to stress-induced proteins. Proc Natl Acad Sci USA 87: 5652–5658

    Google Scholar 

  • Messner HA (1991) Bone marrow transplantation in hemopoietic malignancies. Curr Op Oncol 3: 245–253

    Article  CAS  Google Scholar 

  • Mukerji B, Chakraborty NG, Sivanandham M (1990) T-cell clones that react against autologous human tumors. Immunol Rev 116: 33–62

    Article  Google Scholar 

  • Notter M, Schirrmacher V (1990) Tumor-specific T-cell clones recognize different protein determinants of autologous human malignant melanoma cells. Int J Cancer 45: 834–841

    Article  PubMed  CAS  Google Scholar 

  • Osband ME. Ross S (1990) Problems in the investigational study and clinical use of cancer immunotherapy. Immunol Today 11: 193–195

    CAS  Google Scholar 

  • Perdrizet GA, Ross SR, Stauss HJ, Singh S, Koeppen H, Schreiber H (1990) Animals bearing malignant grafts reject normal grafts that express through gene transfer the same antigen. J Exp Med 171: 1205–1220

    Article  PubMed  CAS  Google Scholar 

  • Porgador A, Feldman M, Eisenbach L (1989) H-rKb transfection of Bi6 melanoma cells results in reduced tumorigenicity and metastatic competence. J Immunogenet 16: 291–303

    Article  PubMed  CAS  Google Scholar 

  • Rosenberg SA, Schwarz SL, Spiess PJ (1988) Combination immunotherapy for cancer: synergistic anti tumor interactions of interleukin-2, alfa interferon and tumor-infiltrating lymphocytes. J Natl Cancer Inst 80: 1393–1397

    Article  PubMed  CAS  Google Scholar 

  • Schirrmacher V (1990) Krebsimpfung mit Tumorzellen. Spektrum der Wissenschaft Januar: 38–50

    Google Scholar 

  • Schirrmacher V, Barz D (1986) Characterization of cellular and extracellular plasmamembrane vesicles from a low metastatic lymphoma (Eb) and its high metastatic variant (ESb): inhibitory capacity in cell-cell interaction systems. Biochem Biophys Acta 860: 236–242

    Article  PubMed  CAS  Google Scholar 

  • Schirrmacher V, Jacobs W (1979) Tumor metastases and cell-mediated immunity in a model systems in DBA/2 mice. VIII. Expression and shedding of Fc gamma receptors on metastatic tumor cell variants. J Supramol Struct 11: 105–111

    Article  PubMed  CAS  Google Scholar 

  • Schirrmacher V, Josimociv-Alasevic O, Osawa H, Diamantstein T (1987) Determination of cell-free interleukin 2 receptor level in the serum of normal animals and of animals bearing II-2 receptor positive tumors with high or low metastatic capacity. Br J Cancer 55: 583–587

    Article  PubMed  CAS  Google Scholar 

  • Sibille C, Chomez P, Wildmann C et al. (1990) Structure of the gene of tum-transplantation antigen p 198: a point-mutation generates a new antigenic peptide. J Exp Med 172: 35–45

    Article  PubMed  CAS  Google Scholar 

  • Slavin S, Nagler A (1991) New developments in bone marrow transplantation. Curr Op Oncol 3: 254–271

    Article  CAS  Google Scholar 

  • Stevenson HC, Foon KA, Kanapa DJ, Favilla T, Beman I, Oldham RK (1984) The potential value of cytapheresis for adoptive immunotherapy of cancer patients. Plasma Ther Transfusion Technol 5: 237–250

    Google Scholar 

  • Stickney DR, Foon KA (1992) Biologic response modifiers: therapeutic approaches to lymphoproliferative diseases. Current Opinion Onco 4: 847–855

    Article  CAS  Google Scholar 

  • Suto R, Srivastava PK (1995) A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269: 1585-1588

    Article  PubMed  CAS  Google Scholar 

  • Szikora J, Van Pel A, Birchard V et al. (1990) Structure of the gene of turn-transplantation antigen P35B: presence of a point mutation in the antigenic allele. EMBO J 9: 104

    Google Scholar 

  • Tepper R, Pattengale P, Leder P (1989) Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 57: 503–512

    Article  PubMed  CAS  Google Scholar 

  • Townsend SE, Allison JP (1993) Tumor rejection after direct costimulation of CD8 + T cells by B7-transfected melanoma cells. Science 259: 368–370

    Article  PubMed  CAS  Google Scholar 

  • Turks LA, Linsley PS, LinH, Brady W, Leiden JM, Wei RQ, Gibson M, Zheng XG, Myrdal S, Gordon D et al. (1992) T cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci USA 89: 1110 2–1110 6

    Google Scholar 

  • Van der Bruggen P, Traversari C, Chomez P et al. (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643

    Article  PubMed  Google Scholar 

  • Versteeg, R, Kruse-Wolters KM, Plomp AC et al. (1989a) Suppression of class I human HLA by c-myc is locus specific. J Exp Med 170: 621–635

    Article  PubMed  CAS  Google Scholar 

  • Versteeg R, Peltenberg L, Plomp AC, Schreier PI (1989 b) High expression of the c-myc oncogene renders melanoma cells prone to lysis by NK cells. J Immunol 143: 4331–4337

    Google Scholar 

Download references

Authors
  1. V. Schirrmacher
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Boehringer Mannheim, Sandhofer Str. 116, 68305, Mannheim, Deutschland

    Eberhard Spanuth

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schirrmacher, V. (1996). Zusammenfassung: immunologische Reaktionsabläufe bei malignen Erkrankungen. In: Spanuth, E. (eds) Malignome und Hämostase. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79744-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-79744-6_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-59253-2

  • Online ISBN: 978-3-642-79744-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation